SCHEMBL30319377

SCHEMBL30319377

CC(=O)c1n[nH]c(=O)c2cc(F)c(F)cc12

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.38
▸ POLB P06746 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ HTT P42858 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ ALPL P05186 1/20 0.35
▸ ALPI P09923 1/20 0.35
▸ ALPG P10696 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ NPC1 O15118 3/20 0.34
▸ RAB9A P51151 3/20 0.34
▸ TSHR P16473 1/20 0.34
▸ PARP1 P09874 2/20 0.33
▸ HCAR2 Q8TDS4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30319370 0.82 TSHR (0.42) KMT2APOLBSMN1; SMN2CYP1A2KDM4E
SCHEMBL30319390 0.76 KMT2A (0.44) KMT2APOLBSMN1; SMN2CYP1A2KDM4E
SCHEMBL24077389 0.75 ATM (0.44) KMT2APOLBSMN1; SMN2MEN1PARP1
SCHEMBL30319401 0.75 KDM4E (0.63) KMT2APOLBSMN1; SMN2CYP1A2KDM4E
SCHEMBL13995824 0.75 KDM4E (0.63) KMT2APOLBSMN1; SMN2CYP1A2KDM4E
SCHEMBL30319337 0.74 AR (0.41) KMT2APOLBSMN1; SMN2CYP1A2KDM4E
SCHEMBL30319413 0.74 POLB (0.47) KMT2APOLBSMN1; SMN2KDM4EL3MBTL1
SCHEMBL29874776 0.68 TSHR (0.39) KMT2APOLBSMN1; SMN2CYP1A2KDM4E
SCHEMBL29875213 0.68 TSHR (0.39) KMT2APOLBSMN1; SMN2CYP1A2KDM4E
SCHEMBL14240098 0.68 CTNNB1 (0.40) POLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4161905-A1 SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF Arbutus Biopharma Corporation (CA) 2023-04-12 — — EP disclosed
Send feedback